Great news. I wonder if Nader's mother in law is
Post# of 150676

This was the trial which Nader tried to use to get Breakthrough Designation, and failed. But which Ohm said should have gotten B.D.
I think it was around then that Andersen announced a trial of Leron with a checkpoint inhibitor -- probably Keytruda. So far as I know, we never heard the results. (Anyone know better?) Ohm said at the time that Leron basically can do everything Keytruda (pembrolizumab) can do, and more. Would you say the same about Trodelvy, Ohm? Does you feel this announcement of further trials indicate that they still don't have a handle on Leron's MOA?

